cytosine has been researched along with Cardiovascular Diseases in 10 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have previously reported that the wild-type cytosine/cytosine genotype of a common Desmin synonymous single nucleotide polymorphism (C > T) (rs1058261) associated with cardiovascular diseases in a cohort of subjects from the Tampere adult population cardiovascular risk study." | 4.12 | The gene variant for desmin rs1058261 may protect against combined cancer and cardiovascular death, the Tampere adult population cardiovascular risk study. ( Kunnas, T; Nikkari, ST; Piesanen, J, 2022) |
| "DNA-based sensors can detect disease biomarkers, including acetone and ethanol for diabetes and H2S for cardiovascular diseases." | 3.83 | Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics. ( Cranford, SW; Wang, ML; Zhang, W, 2016) |
| "Hydralazine was administered to cohorts of 4 patients at the following dose levels: I) 50 mg/day, II) 75 mg/day, III) 100 mg/day and IV) 150 mg/day." | 2.71 | A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. ( Angeles, E; Cabrera, G; Cetina, L; Chanona-Vilchis, J; Chavez-Blanco, A; Duenas-González, A; Perez-Cardenas, E; Revilla-Vazquez, A; Sandoval, K; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C; Zambrano, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piesanen, J | 1 |
| Kunnas, T | 1 |
| Nikkari, ST | 1 |
| Zhang, W | 1 |
| Wang, ML | 1 |
| Cranford, SW | 1 |
| Pigossi, SC | 1 |
| Alvim-Pereira, F | 1 |
| Montes, CC | 1 |
| Finoti, LS | 1 |
| Secolin, R | 1 |
| Trevilatto, PC | 1 |
| Scarel-Caminaga, RM | 1 |
| Jenny, NS | 1 |
| Tracy, RP | 1 |
| Ogg, MS | 1 |
| Luong, le A | 1 |
| Kuller, LH | 1 |
| Arnold, AM | 1 |
| Sharrett, AR | 1 |
| Humphries, SE | 1 |
| Rao, M | 1 |
| Guo, D | 1 |
| Jaber, BL | 1 |
| Tighiouart, H | 1 |
| Pereira, BJ | 1 |
| Balakrishnan, VS | 1 |
| Doney, AS | 1 |
| Fischer, B | 1 |
| Leese, G | 1 |
| Morris, AD | 1 |
| Palmer, CN | 1 |
| Zambrano, P | 1 |
| Segura-Pacheco, B | 1 |
| Perez-Cardenas, E | 1 |
| Cetina, L | 1 |
| Revilla-Vazquez, A | 1 |
| Taja-Chayeb, L | 1 |
| Chavez-Blanco, A | 1 |
| Angeles, E | 1 |
| Cabrera, G | 1 |
| Sandoval, K | 1 |
| Trejo-Becerril, C | 1 |
| Chanona-Vilchis, J | 1 |
| Duenas-González, A | 1 |
| Klujber, V | 1 |
| Lengyel, B | 1 |
| Szabó, T | 1 |
| Németh, A | 1 |
| Dobó, M | 1 |
| Rossi, GP | 1 |
| Maiolino, G | 1 |
| Zanchetta, M | 1 |
| Sticchi, D | 1 |
| Pedon, L | 1 |
| Cesari, M | 1 |
| Montemurro, D | 1 |
| De Toni, R | 1 |
| Zavattiero, S | 1 |
| Pessina, AC | 1 |
| Hoefle, G | 1 |
| Muendlein, A | 1 |
| Saely, CH | 1 |
| Risch, L | 1 |
| Rein, P | 1 |
| Koch, L | 1 |
| Schmid, F | 1 |
| Aczel, S | 1 |
| Marte, T | 1 |
| Langer, P | 1 |
| Drexel, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00005692] | 0 participants | Observational | 1992-04-30 | Completed | |||
| Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)[NCT02783469] | 1,915 participants (Actual) | Observational | 2004-10-31 | Completed | |||
| "Phase III Clinical Trial: Evaluation of the Combination of TRANSKRIP ® Plus Carboplatin and Paclitaxel as First Line Chemotherapy on Survival of Patients With Recurrent - Persistent Cervical Cancer"[NCT02446652] | Phase 3 | 230 participants (Anticipated) | Interventional | 2015-07-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for cytosine and Cardiovascular Diseases
| Article | Year |
|---|---|
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes.
Topics: 5-Methylcytosine; Adult; Aged; Binding Sites; Biopsy; Cardiovascular Diseases; Cohort Studies; Cytos | 2005 |
9 other studies available for cytosine and Cardiovascular Diseases
| Article | Year |
|---|---|
The gene variant for desmin rs1058261 may protect against combined cancer and cardiovascular death, the Tampere adult population cardiovascular risk study.
Topics: Adult; Cardiovascular Diseases; Cytosine; Desmin; Genotype; Heart Disease Risk Factors; Humans; Neop | 2022 |
Ranking of Molecular Biomarker Interaction with Targeted DNA Nucleobases via Full Atomistic Molecular Dynamics.
Topics: Acetone; Adenine; Biomarkers; Biosensing Techniques; Cardiovascular Diseases; Cytosine; Diabetes Mel | 2016 |
Genetic association study between Interleukin 10 gene and dental implant loss.
Topics: Adenine; Alleles; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular | 2012 |
In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease.
Topics: Age Factors; Aged; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cytosine; Female; Foll | 2002 |
Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.
Topics: Aged; Cardiovascular Diseases; Codon; Cohort Studies; Cytosine; Death; Female; Genetic Predispositio | 2004 |
Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study.
Topics: Age Factors; Alanine; Alleles; Amino Acid Substitution; Cardiovascular Diseases; Cohort Studies; Cyt | 2004 |
[The plasma homocysteine, folic acid and vitamin B12 levels in young people with high risk for cardiovascular disease and its relation to metylentetrahydrofolate reductase (MTHFR) gene polymorphism].
Topics: Adult; Cardiovascular Diseases; Cytosine; Female; Folic Acid; Heterozygote; Homocysteine; Humans; Im | 2005 |
The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Chest Pain; Cohort Studies; Coronary Disease; Cytosine; F | 2006 |
The -11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men.
Topics: Adiponectin; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Coronary Artery Disease; | 2007 |